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Abstract
Background:  Renal cell carcinoma during pregnancy is uncommon. We present a rare case, highlighting
the dilemma faced by the patient and the challenge of deciding the appropriate management option.
Patient: A 28-year-old patient presented at 14 weeks of gestation with a 2-month history of left loin pain.
Physical examination revealed a ballotable left flank mass. Abdominal ultrasound showed a heterogeneous
lower-pole left renal mass measuring 9.2 cm ×  7.0 cm and a viable intrauterine 14-week gestation. The
patient declined magnetic resonance imaging (MRI) study for further evaluation, even after counseling on
the acceptable safety of the modality.
Intervention:  She also declined radical nephrectomy during pregnancy for fear of spontaneous abortion.
She subsequently underwent left radicalnephrectomy after delivery. Histopathological examination of the
resected specimen showed a Fuhrman grade-III clear renal cell carcinoma confined to the kidney, stage
pT1b.
Conclusion:  Renal malignancy though rare in pregnancy can however occur. The key treatment is radical
nephrectomy. Offering this very invasive treatment and getting patient to accept the treatment at any stage
of pregnancy is difficult.
© 2015 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
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Introduction
Renal cell carcinoma (RCC) in pregnancy is a very rare entity.
It is emotionally devastating for a young woman and her family,
overshadowing the joy of pregnancy. It also presents a daunting
therapeutic dilemma for the urologist and the obstetrician.
To our knowledge, only 50 cases have been reported in the litera-
ture [1]. No case has been reported from our center. The apparent
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challenges in managing RCC in pregnant patients are the choice of
appropriate investigation modalities as well as making appropriate
and acceptable therapeutic decisions. We herein report a case of
RCC in pregnancy and highlight the unique dilemma faced by the
patient and the challenges in managing the disease.
Case  report
A 28-year-old banker, para 1 gravida 2, presented at 14 weeks of
gestation with a two-month history of left flank pain. She did not
report any hematuria or weight loss. Physical examination revealed
no pallor, however abdominal examination revealed a ballotable left
flank mass.
Laboratory investigation showed no red blood cells in the urine.
Abdominal ultrasound revealed a heterogeneous lower-pole left
renal mass measuring 9.2 cm ×  7.0 cm, an intrauterine gestational
sac and viable fetus with a bi-parietal diameter (BPD) of 33.0 cm.
The surgical options were discussed with the patient, her husband
and the other family members. The possibility of spontaneous abor-
tion, if radical nephrectomy was done at 14 weeks of gestation, was
explained to her. She declined the procedure and rather opted for
a Cesarean section and simultaneous left radical nephrectomy in
the third trimester of gestation. However, in the third trimester she
expressed the desire for spontaneous vaginal delivery (SVD) and
asked for the radical nephrectomy to be delayed. She had the SVD
at 40 weeks of gestation.
Postpartum abdominal computed tomography (Fig. 1) established
the lower-pole mass measuring 8.0 cm ×  7.0 cm.
The patient underwent a left radical nephrectomy two weeks post-
partum. The immediate postoperative course was uneventful. Repeat
CT scan of the abdomen was routinely done during the follow-up
visits, and the patient has remained disease-free 2 years after surgery.
Figure  1  Abdominal CT showing a heterogeneous enhancing left
renal mass.
Figure  2  Gross appearance of the surgical specimen.
Gross pathologic examination (Fig. 2) showed a 7 cm encapsulated
solid mass in the inferior pole of the left kidney (pT1b, 2004 TNM
classification). The histological examination of the resected speci-
men showed a Fuhrman grade-III clear RCC (Figs. 2 and 3).
Discussion
Renal cell carcinoma (RCC) in general represents 3% of adult malig-
nancies [2,3]. It is, however, the commonest urological malignancy
reported in pregnancy [4].
The apparent rare occurrence of RCC in pregnancy is due to the fact
that the malignancy is commoner in older patients between 50 and
70 years of age. The peak incidence occurs after the 5th decade of
life [2].
RCC in pregnancy commonly presents with a flank mass and flank
pain, sometimes it also presents with the classical triad (hematuria,
flank pain, abdominal mass). However, the most common symp-
tom of RCC detected during pregnancy is flank mass. This may
be attributed to the increased frequency of abdominal examinations
during pregnancy. On the other hand, the gravid uterus may some-
times obscure the mass, especially during the second and the third
trimester, thus making the diagnosis difficult [4].
Flank pain is the second most frequent presentation and may some-
times be the only presenting symptom, especially when the mass
is obscured by the gravid uterus. The attribution of flank pain
to commoner causes of gestational flank pain like pyelonephritis,
hydronephrosis and urolithiasis may also delay the diagnosis in
some cases of renal malignancy in pregnancy.
Hematuria is reported less commonly, as expected with RCC in preg-
nancy considering the increased renal blood flow during pregnancy
[2].
Like in the non-pregnant population, the classical triad of hematuria,
palpable mass and pain is a feature of late disease [5].
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Figure  3  Microscopy of the specimen showing neoplastic cells exhibiting hyperchromasia, highly vacuolated cytoplasm with numerous congested
blood vessels. There is also loss of normal renal architecture (the slide to the left is of low power magnification (10×), while that to the right is high
power magnification (40×); both slides prepared with hematoxylin–eosin stain).
Establishing the diagnosis of renal malignancy requires imaging
modalities. Ultrasonography is the preferred diagnostic modality
in pregnancy because it does not carry the risk of radiation to the
developing fetus. However, its drawback lies in the fact that ultra-
sonography is operator-dependent. Therefore, the diagnosis and full
characterization of the renal mass may be suboptimal.
Computed tomography (CT) scan is the imaging modality of choice
for the diagnosis of renal masses [6]. However, there is usually some
reluctance to undertake CT scan during pregnancy because of the
risk of exposing the fetus to radiation. This makes full evaluation
of the tumor difficult. Also, the radiation dose to the fetus is not
known.
Magnetic resonance imaging (MRI) is reproducible and a good, even
though expensive, alternative to CT scan for the evaluation of renal
masses in pregnant patients [7]. It accurately evaluates the local
tumor size and location, the involvement of the adjacent structures
and tumor thrombi in the renal vein and inferior vena cava. Gadolin-
ium, the contrast agent used in MRI contrast study, crosses the
placenta barrier, but no adverse effect on the fetus has been recorded.
The European Society of Radiology guideline has approved it for use
in all stages of pregnancy. However, gadolinium has been labeled a
category C compound by the Food and Drug Administration because
of the lack of epidemiologic studies concerning exposure in the first
trimester of pregnancy [8,9].
Radical nephrectomy, either open or via the laparoscopic approach,
is the gold standard treatment for RCC [10]. Laparoscopic rad-
ical nephrectomy during pregnancy is becoming increasingly
accepted where feasible. O’Connor and colleagues [11] were the
first to report successful laparoscopic radical nephrectomy dur-
ing pregnancy. Since then many other cases have been reported
[12,13].
The optimal time for surgery during pregnancy and the conse-
quences of surgery on the maternal and fetal well-being are major
considerations. The second trimester is generally identified as the
ideal time for performing non-obstetric surgery during pregnancy.
The first trimester carries a higher risk of abortion and exposure to
teratogens, whereas in the third trimester there is a higher risk of
premature labor due to uterine irritation [12].
The treatment of RCC in pregnancy has been reviewed, but the
guidelines are not perfect yet. Louglin [4] recommends radical
nephrectomy for all women with RCC discovered during the first
trimester. For RCC discovered during the second trimester he advo-
cates observation until a gestational age of 28 weeks to make sure
that fetal lung maturity has been attained before radical nephrec-
tomy is carried out. And for RCC discovered in the third trimester he
recommends that radical nephrectomy with simultaneous Cesarean
section be carried out.
Other investigators recommend radical nephrectomy irrespective of
the stage of pregnancy [14,15].
In our case, the relevant management challenges became a
prominent issue. The patient declined MRI for an adequate char-
acterization of the tumor. She also declined radical nephrectomy in
the third trimester of pregnancy. Instead, she decided to have a spon-
taneous vaginal delivery before accepting to undergo surgery. She
underwent surgery during the puerperium and has been disease-free
now for two years.
Conclusion
Renal cell carcinoma, though rare in pregnancy, may occur. The
key treatment is radical nephrectomy. Offering this considerably
invasive treatment and getting the patient to accept the treatment at
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any stage of her pregnancy may be difficult. While it is necessary
to consider the patient’s opinion, the standard recommendation for
the management of RCC in pregnancy must be clearly explained
to the patient. In our patient the prognosis has remained favorable,
principally because the malignancy was still confined to the kidney.
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